Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Commercial Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,647 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,929 · Balance 67,303 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,668 · Balance 68,971 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 2,527 · Balance 71,498 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,292 · Balance 72,790 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,143 · Balance 69,647 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,929 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,668 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,105 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 2,527 · Balance 10,105 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,754 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,292 · Balance 7,754 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2025 Filed Mar 13, 2025 20:40 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 15,430 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000074 · wk-form4_1741898412.xml · derivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,430 Underlying: Common Stock · 15,430 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:40 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 23,145 | $0.00 Strike: $43.10 | $0.00 |
DisclosureSEC source: 0001576280-25-000074 · wk-form4_1741898412.xml · derivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,145 Underlying: Common Stock · 23,145 shares Expires 2035-03-12 F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 5,686 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000056 · wk-form4_1741129889.xml · derivative · entry 4 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,376 Underlying: Common Stock · 5,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,566 | $42.55 | $66,633.30 |
DisclosureSEC source: 0001576280-25-000056 · wk-form4_1741129889.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,789 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000056 · wk-form4_1741129889.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000014 · wk-form4_1735945160.xml · derivative · entry 5 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,671 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,928 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000014 · wk-form4_1735945160.xml · derivative · entry 4 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,499 Underlying: Common Stock · 1,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,183 | $30.55 | $36,140.65 |
DisclosureSEC source: 0001576280-25-000014 · wk-form4_1735945160.xml · nonDerivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,669 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000014 · wk-form4_1735945160.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000014 · wk-form4_1735945160.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,402 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000307 · wk-form4_1734390955.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,411 Underlying: Common Stock · 1,402 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 597 | $34.76 | $20,751.72 |
DisclosureSEC source: 0001576280-24-000307 · wk-form4_1734390955.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,257 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000307 · wk-form4_1734390955.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 30,164 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000271 · wk-form4_1731453100.xml · derivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,164 Underlying: Common Stock · 30,164 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 45,246 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001576280-24-000271 · wk-form4_1731453100.xml · derivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,246 Underlying: Common Stock · 45,246 shares Expires 2034-11-08 F1 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000238 · wk-form4_1727902387.xml · derivative · entry 5 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,338 Underlying: Common Stock · 6,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,929 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000238 · wk-form4_1727902387.xml · derivative · entry 4 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,427 Underlying: Common Stock · 1,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,620 | $22.12 | $80,074.40 |
DisclosureSEC source: 0001576280-24-000238 · wk-form4_1727902387.xml · nonDerivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,452 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000238 · wk-form4_1727902387.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000238 · wk-form4_1727902387.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:29 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,402 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000216 · wk-form4_1726522185.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,813 Underlying: Common Stock · 1,402 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:29 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 597 | $26.79 | $15,993.63 |
DisclosureSEC source: 0001576280-24-000216 · wk-form4_1726522185.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,574 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:29 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000216 · wk-form4_1726522185.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,928 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000168 · wk-form4_1719953743.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,356 Underlying: Common Stock · 1,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 758 | $28.26 | $21,421.08 |
DisclosureSEC source: 0001576280-24-000168 · wk-form4_1719953743.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,769 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000168 · wk-form4_1719953743.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 5,523 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000148 · wk-form4_1718664004.xml · derivative · entry 5 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,215 Underlying: Common Stock · 5,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F5 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,879 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000148 · wk-form4_1718664004.xml · derivative · entry 4 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,879 Underlying: Common Stock · 4,879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,870 | $30.21 | $86,702.70 |
DisclosureSEC source: 0001576280-24-000148 · wk-form4_1718664004.xml · nonDerivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,599 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000148 · wk-form4_1718664004.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000148 · wk-form4_1718664004.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,929 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000082 · wk-form4_1712095607.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,284 Underlying: Common Stock · 1,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 531 | $20.25 | $10,752.75 |
DisclosureSEC source: 0001576280-24-000082 · wk-form4_1712095607.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,971 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000082 · wk-form4_1712095607.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,928 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000008 · wk-form4_1704329149.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,213 Underlying: COMMON STOCK · 1,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 634 | $27.05 | $17,149.70 |
DisclosureSEC source: 0001576280-24-000008 · wk-form4_1704329149.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,573 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000008 · wk-form4_1704329149.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:22 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 19,907 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000213 · wk-form4_1702678921.xml · derivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,907 Underlying: COMMON STOCK · 19,907 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:22 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 29,861 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001576280-23-000213 · wk-form4_1702678921.xml · derivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,861 Underlying: COMMON STOCK · 29,861 shares Expires 2033-12-13 F1 · derivative.exercise_date: This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 7,713 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000169 · wk-form4_1696281611.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,141 Underlying: COMMON STOCK · 7,713 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,128 | $29.64 | $63,073.92 |
DisclosureSEC source: 0001576280-23-000169 · wk-form4_1696281611.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,279 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 7,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000169 · wk-form4_1696281611.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 4,879 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000105 · wk-form4_1686953760.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,758 Underlying: COMMON STOCK · 4,879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,346 | $37.86 | $50,959.56 |
DisclosureSEC source: 0001576280-23-000105 · wk-form4_1686953760.xml · nonDerivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,694 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000105 · wk-form4_1686953760.xml · nonDerivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 16,738 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000083 · wk-form4_1686692410.xml · derivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,738 Underlying: COMMON STOCK · 16,738 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 25,107 | $0.00 Strike: $32.86 | $0.00 |
DisclosureSEC source: 0001576280-23-000083 · wk-form4_1686692410.xml · derivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,107 Underlying: COMMON STOCK · 25,107 shares Expires 2033-06-09 F1 · derivative.exercise_date: This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 9, 2024, and the remaining 67% of the shares vests in equal installments on each monthly anniversary of June 9, 2024, during the two-year period thereafter. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:39 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 30,854 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000102 · wf-form4_166803355413279.xml · derivative · entry 2 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,854 Underlying: COMMON STOCK · 30,854 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:39 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 61,708 | $0.00 Strike: $47.20 | $0.00 |
DisclosureSEC source: 0001576280-22-000102 · wf-form4_166803355413279.xml · derivative · entry 1 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,708 Underlying: COMMON STOCK · 61,708 shares Expires 2032-11-06 F1 · derivative.exercise_date: This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 4,879 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000044 · wf-form4_165550316922620.xml · derivative · entry 3 Freeman Chris · CIK 0001871615 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,637 Underlying: COMMON STOCK · 4,879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable to Restricted Stock Units Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.